Gliotoxin (from Gladiocladium fimbriatum) ≥97% (by HPLC, TLC)

Supplier: ENZO LIFE SCIENCES

BMLPI1290002 BMLPI1290010
ENZOBMLPI1290002EA 161 EUR
ENZOBMLPI1290002 ENZOBMLPI1290010
Gliotoxin (from Gladiocladium fimbriatum) ≥97% (by HPLC, TLC)
Gliotoxin

Immunomodulating mycotoxin which acts by blocking membrane thiol groups. Inhibits the chymotrypsin-like activity of the 20S proteasome in a non-competitive manner. Causes apoptotic cell death in macrophages and thymocytes. Induces Ca2+ release from intact rat liver mitochondria. Inhibits the activation of transcription factor NF-κB in response to a variety of stimuli in T and B cells. Displays anti-inflammatory activity in vivo. Antioxidant. Inhibitor of farnesyltransferase and geranylgeranyltransferase I. A negative control analog is available. Displays anti-tumor activity against breast cancer in vivo.


  • Proteasome inhibitor


White to yellow crystalline solid.


Soluble in DMSO or methanol (10mg/ml).

Formula: C₁₃H₁₄N₂O₄S₂
Storage Temperature: Freezer
CAS Number: 67-99-2

Order Now


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR